Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo‐controlled, randomized, double‐blinded, parallel‐group comparison/open‐label clinical trial,European Journal of Neurology

当前位置： X-MOL 学术 › Eur. J. Neurol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo‐controlled, randomized, double‐blinded, parallel‐group comparison/open‐label clinical trial
European Journal of Neurology ( IF 4.5 ) Pub Date : 2021-01-04 , DOI: 10.1111/ene.14714
Masamitsu Hyodo ₁ , Asuka Nagao ₁ , Kento Asano ₂ , Masahiko Sakaguchi ₃ , Kenji Mizoguchi ₄ , Koichi Omori ₅ , Yasuhiro Tada ₆ , Hiromitsu Hatakeyama ₇ , Nobuhiko Oridate ₇ , Kensei Naito ₈ , Yoshihiro Iwata ₉ , Hirotaka Shinomiya ₁₀ , Hirotaka Hara ₁₁ , Tetsuji Sanuki ₁₂ , Eiji Yumoto ₁₃

Affiliation

Department of Otolaryngology-Head and Neck Surgery, Kochi University, Nankoku, Japan.
Department of Medical Innovation, Osaka University Hospital, Suita, Japan.
Department of Engineering Informatics, Osaka Electro Communication University, Neyagawa, Japan.
Department of Otolaryngology-Head and Neck Surgery, Hokkaido University, Sapporo, Japan.
Department of Otolaryngology-Head and Neck Surgery, Kyoto University, Kyoto, Japan.
Department of Otolaryngology, Fukushima Medical University, Fukushima, Japan.
Department of Otolaryngology, Yokohama City University, Yokohama, Japan.
Academy of Nursing, Fujita Health University, Toyoake, Japan.
Department of Otolaryngology-Head and Neck Surgery, Fujita Health University, Toyoake, Japan.
Department of Otolaryngology-Head and Neck Surgery, Kobe University, Kobe.
Department of Otolaryngology, Kawasaki Medical School, Kurashiki, Japan.
Department of Otolaryngology, Nagoya City University, Nagoya, Japan.
Department of Otolaryngology, Kumamoto University, Kumamoto, Japan.

Botulinum toxin (BT) injection into the laryngeal muscles has been a standard treatment for spasmodic dysphonia (SD). However, few high‐quality clinical studies have appeared, and BT is used off‐label in most countries.

中文翻译：